INDO US BIOTECH
Back to Balance Sheet
|
INDO US BIOTECH Last 5 Year Net Current Assets History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹70 Cr | ₹56 Cr | ₹48 Cr | ₹35 Cr | ₹20 Cr |
What is the latest Net Current Assets ratio of INDO US BIOTECH ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹70 Cr |
| Mar2024 | ₹56 Cr |
| Mar2023 | ₹48 Cr |
| Mar2022 | ₹35 Cr |
| Mar2021 | ₹20 Cr |
How is Net Current Assets of INDO US BIOTECH Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹70 Cr | 26.54 | |
| Mar2024 | ₹56 Cr | 16.82 | |
| Mar2023 | ₹48 Cr | 36.64 | |
| Mar2022 | ₹35 Cr | 72.77 | |
| Mar2021 | ₹20 Cr | - | |
Compare Net Current Assets of peers of INDO US BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDO US BIOTECH | ₹164.8 Cr | -3.6% | -2.4% | -45.9% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,033.6 Cr | 3.2% | -2.8% | -31.8% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,219.5 Cr | 4.7% | 4.4% | 7.9% | Stock Analytics | |
| AVT NATURAL PRODUCTS | ₹1,306.3 Cr | -2.3% | 23% | 20% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹948.7 Cr | 1.7% | 4.1% | NA | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹481.2 Cr | -1.4% | -8.9% | -9.5% | Stock Analytics | |
INDO US BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDO US BIOTECH | -3.6% |
-2.4% |
-45.9% |
| SENSEX | -0.8% |
0.2% |
-6% |
You may also like the below Video Courses